Year archive

Gubra A/S — 2024 filings

All 28 regulatory filings released by Gubra A/S (GUBRA) in 2024, sourced directly from the official regulator.

28 Filings

2024 Period

2024 filings (28)

Filing	Released	Lang
Gubra announces positive GUBamy Phase 1 SAD data (correction) Regulatory Filings	2024-11-13	English
Gubra announces positive GUBamy Phase 1 SAD data Regulatory Filings	2024-11-13	English
Gubra announces discontinuation of development of NYP2 in obesity with Boehringer Ingelheim Regulatory Filings	2024-10-31	English
Major shareholder announcement Major Shareholding Notification	2024-09-06	English
Interim report H1 2024: Strong performance across Gubra Interim / Quarterly Report H1 2024	2024-08-22	English
Interim report H1 2024: Strong performance across Gubra Interim / Quarterly Report H1 2024	2024-08-22	English
Gubra raises financial outlook for 2024 Earnings Release FY 2024	2024-08-21	English
Reporting of transactions made by persons discharging managerial responsibilities and persons closely associated with them in Gubra A/S' shares Director's Dealing	2024-07-10	English
Reporting of transactions made by persons discharging managerial responsibilities and persons closely associated with them in Gubra A/S' shares Director's Dealing	2024-07-02	English
Boehringer Ingelheim and Gubra announce start of clinical development of a potential first-in-class, triple agonist, obesity treatment Regulatory Filings	2024-07-01	English
Reporting of transactions made by persons discharging managerial responsibilities and persons closely associated with them in Gubra A/S' shares Director's Dealing	2024-06-28	English
Reporting of transactions made by persons discharging managerial responsibilities and persons closely associated with them in Gubra A/S' shares Director's Dealing	2024-06-04	English
Reporting of transactions made by persons discharging managerial responsibilities and persons closely associated with them in Gubra A/S' shares Director's Dealing	2024-06-04	English
Gubra raises financial outlook for 2024 Earnings Release FY 2024	2024-05-06	English
Reporting of transactions made by persons discharging managerial responsibilities and persons closely associated with them in Gubra A/S' shares Director's Dealing	2024-04-03	English
Reporting of transactions made by persons discharging managerial responsibilities and persons closely associated with them in Gubra A/S' shares Director's Dealing	2024-04-03	English
Reporting of transactions made by persons discharging managerial responsibilities and persons closely associated with them in Gubra A/S' shares Director's Dealing	2024-03-27	English
Major shareholder announcement: The Capital Group Companies Inc. Major Shareholding Notification	2024-03-26	English
Major shareholder announcement: The Capital Group Companies Inc. Major Shareholding Notification	2024-03-26	English
Major shareholder announcement: The Capital Group Companies Inc. Major Shareholding Notification	2024-03-26	English
Reporting of transactions made by persons discharging managerial responsibilities and persons closely associated with them in Gubra A/S' shares Director's Dealing	2024-03-25	English
Major shareholder announcement Major Shareholding Notification	2024-03-25	English
Major shareholder announcement Major Shareholding Notification	2024-03-25	English
Reporting of transactions made by persons discharging managerial responsibilities and persons closely associated with them in Gubra A/S' shares Director's Dealing	2024-03-04	English
Annual Report 2023 – Revenue in the CRO business growing by 29% to record high level Earnings Release FY 2023	2024-02-28	English
Annual Report 2023 – Revenue in the CRO business growing by 29% to record high level Annual Report FY 2023	2024-02-28	Danish
Annual Report 2023 – Revenue in the CRO business growing by 29% to record high level Annual Report FY 2023	2024-02-28	English
Gubra concludes the research agreement with UK Biotech Regulatory Filings	2024-01-26	English